Shareholder Alert: Grabar Law Office Investigates Claims on Behalf of Shareholders of Biogen, Inc. (BIIB) After It Agrees to Pay $900 Million for Improper Kickbacks

Philadelphia, Pennsylvania--(Newsfile Corp. - December 7, 2022) - As announced by the DOJ, Biogen has agreed to pay $900 million to settle federal and state claims that it paid kickbacks to physicians to induce them to prescribe the company's multiple sclerosis drugs from January 1, 2009, through March 18, 2014.

If you are a current long-term Biogen shareholder, you may be able seek corporate reforms, the return of funds expended defending litigation back to company coffers, and a court approved incentive award if appropriate.

If you would like to learn more about this matter at no cost to you, visit https://grabarlaw.com/the-latest/biogen-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085.

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/147115